These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 21088095

  • 1. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H, Lewin A, Lukić T, Goodin T, Wei Chen.
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):349-57. PubMed ID: 21088095
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
    Weiss RJ, Saunders E, Greathouse M.
    Clin Ther; 2011 Sep; 33(9):1150-61. PubMed ID: 21864908
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A, Punzi H, Luo X, Stapff M.
    Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M, NAC-MD-01 Study Investigators.
    Lancet; 2014 May 31; 383(9932):1889-98. PubMed ID: 24881993
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 15; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun 27; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 11. Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial.
    Lewin A, Lasseter KC, Dong F, Whalen JC.
    J Am Soc Hypertens; 2012 Jun 27; 6(3):228-36. PubMed ID: 22421631
    [Abstract] [Full Text] [Related]

  • 12. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
    Lefebvre J, Poirier L, Poirier P, Turgeon J, Lacourciere Y.
    Br J Clin Pharmacol; 2007 May 27; 63(5):575-82. PubMed ID: 17094780
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 27; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 14. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ, Agrawal R, Lichtenthal A, Mäkel W, Fici F.
    Am J Ther; 2006 Dec 27; 13(3):192-7. PubMed ID: 16772759
    [Abstract] [Full Text] [Related]

  • 15. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O, Ertem B, Altun A.
    Anadolu Kardiyol Derg; 2011 Jun 27; 11(4):310-3. PubMed ID: 21543293
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol: a new beta blocker on the horizon.
    Katira R, Chauhan A.
    Indian Heart J; 2000 Jun 27; 52(1):86-8. PubMed ID: 10820942
    [No Abstract] [Full Text] [Related]

  • 17. Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.
    Neutel JM, Smith DH, Gradman AH.
    J Hum Hypertens; 2010 Jan 27; 24(1):64-73. PubMed ID: 19404314
    [Abstract] [Full Text] [Related]

  • 18. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.
    Am J Ther; 1999 May 27; 6(3):137-47. PubMed ID: 10423656
    [Abstract] [Full Text] [Related]

  • 19. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
    Lacourcière Y, Lefebvre J, Poirier L, Archambault F, Arnott W.
    Am J Hypertens; 1994 Feb 27; 7(2):137-45. PubMed ID: 8179848
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol/hydrochlorothiazide (HCTZ) combination in patients with essential hypertension: a pooled analysis from five non-interventional studies with a focus on diabetic and elderly patients.
    Malacco E.
    Eur Rev Med Pharmacol Sci; 2010 May 27; 14(5):427-34. PubMed ID: 20556921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.